^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Adrenal Cortex Carcinoma |
| Drug: | Keytruda (pembrolizumab) (PD1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Adrenocortical Carcinoma: other recommended regimens... Pembrolizumab + Mitotane
Secondary therapy:
mitotane
